Peptide Storage: How to Store Lyophilised Peptides Correctly
How to store lyophilised peptides: why degradation starts above +4°C, the correct −20°C cold-chain method, and how freeze-thaw cycling damages peptides.
Lyophilisation (freeze-drying) is the primary preservation method for research-grade peptides because it removes the aqueous phase that mediates the majority of chemical degradation pathways. By subliming water under reduced pressure, the process arrests hydrolysis, oxidation, and microbial activity simultaneously, yielding a dry powder with a molecular mobility so low that most degradation reactions become negligible at recommended storage temperatures. Understanding the thermodynamic and chemical basis of peptide instability is essential context for any UK laboratory establishing a cold-chain storage protocol.
Why lyophilisation preserves peptide integrity
In solution, water molecules solvate the peptide backbone and reactive side chains, providing the molecular mobility necessary for hydrolysis, deamidation, and oxidation reactions. Lyophilisation reduces water activity (aw) to values typically below 0.1, effectively immobilising reactant molecules relative to one another. Differential scanning calorimetry (DSC) studies of lyophilised peptide cakes confirm that the glass transition temperature (Tg) of a well-formulated lyophilisate is often 50–80°C above the recommended storage temperature of −20°C, meaning the system is deep in the glassy state where molecular diffusion — and therefore degradation — is orders of magnitude slower than in the rubbery or liquid phase.
Degradation kinetics above +4°C
Even in the solid state, residual moisture content and temperature interact to determine degradation rate. The Arrhenius relationship predicts that a 10°C increase in temperature roughly doubles the reaction rate constant for most chemical degradation pathways. For lyophilised peptides with residual moisture above approximately 1–2% w/w, storage at ambient temperature (+20 to +25°C) can result in measurable purity loss within weeks through hydrolytic and oxidative mechanisms. Peptides stored continuously at −20°C in sealed amber vials with residual moisture below 1% are documented in the pharmaceutical stability literature to retain >98% purity for periods of 24 months or longer.
Disulphide bond oxidation and structural consequences
Peptides containing cysteine residues are particularly vulnerable to oxidative degradation. Free thiol groups (–SH) on cysteine side chains undergo oxidation to form disulphide bonds (–S–S–) either intra- or intermolecularly. Intramolecular disulphide formation can alter the tertiary structure of the peptide, changing its conformation relative to the intended research compound. Intermolecular disulphide formation drives aggregation, producing dimers and higher-order oligomers that are analytically distinct from the monomer of interest. Both outcomes are problematic in in-vitro assay systems where the identity and concentration of the test compound must be precisely defined. Storage at −20°C in an inert, desiccated atmosphere minimises dissolved oxygen availability and reduces thiol oxidation rates substantially.
Freeze-thaw cycling damage
Once reconstituted into aqueous solution, a peptide is fully susceptible to solution-phase degradation mechanisms. Each freeze-thaw cycle introduces additional stress: during freezing, ice crystal formation concentrates solutes and can disrupt non-covalent structural features; during thawing, transient local concentration gradients promote intermolecular reactions including disulphide formation and aggregation. For research applications requiring repeated sampling from the same vial, the correct protocol is to aliquot the reconstituted solution into single-use volumes prior to the first freezing step, thereby avoiding repeated freeze-thaw of the bulk solution entirely.
The correct cold-chain storage protocol
Long-term lyophilised storage: −20°C in a non-frost-free freezer (frost-free cycles cause repeated freeze-thaw events), sealed in original amber vial with desiccant sachet Short-term post-reconstitution storage: +4°C (refrigerator, not freezer) for no more than 28 days; use bacteriostatic water to inhibit microbial growth in multi-draw scenarios Desiccant use: include silica gel desiccant in the storage container at all times; replace desiccant if it reaches capacity (indicated by colour change on indicating varieties) Amber vials: UV light degrades peptide bonds via photochemical mechanisms; amber glass or opaque storage minimises photodegradation Avoid frost-free freezers: the defrost cycling in frost-free units repeatedly warms contents to above 0°C, effectively cycling the peptide through partial thaw events Shipping cold-chain: Vivera Labs ships with cold-pack insulation to maintain temperatures below +8°C during UK transit Practical checklist for UK laboratories
On receipt of a lyophilised peptide shipment: inspect the vial for physical integrity; transfer immediately to −20°C storage with desiccant; record the receipt date and batch number; do not reconstitute more material than required for the immediate experiment. For peptides not accessed within six months, re-verify purity by HPLC before use in experiments where baseline purity is a critical variable. All Vivera Labs peptides are supplied as lyophilised research materials for in-vitro laboratory research use only.
Frequently Asked Questions What temperature should lyophilised peptides be stored at? Long-term lyophilised storage is at −20°C in a non-frost-free freezer, sealed in the original amber vial with a desiccant sachet. Peptides stored continuously at −20°C in sealed amber vials with residual moisture below 1% are documented in the pharmaceutical stability literature to retain over 98% purity for 24 months or longer. Amber glass minimises photodegradation of peptide bonds by UV light.
Why should you avoid frost-free freezers for peptide storage? Frost-free units run a defrost cycle that repeatedly warms contents to above 0°C, effectively cycling the peptide through partial thaw events. Each freeze-thaw event introduces stress, so a non-frost-free freezer is used for long-term lyophilised storage.
How does freeze-thaw cycling damage peptides? During freezing, ice crystal formation concentrates solutes and can disrupt non-covalent structural features; during thawing, transient local concentration gradients promote intermolecular reactions including disulphide formation and aggregation. For applications requiring repeated sampling, the correct protocol is to aliquot the reconstituted solution into single-use volumes before the first freezing step, avoiding repeated freeze-thaw of the bulk solution entirely.
How long can a reconstituted peptide be stored? Once reconstituted into aqueous solution, a peptide is fully susceptible to solution-phase degradation. Short-term post-reconstitution storage is at +4°C in a refrigerator, not a freezer, for no more than 28 days, using bacteriostatic water to inhibit microbial growth in multi-draw scenarios. All Vivera Labs peptides are supplied as lyophilised research materials for in-vitro laboratory research use only.
Related
Continue reading
For in-vitro laboratory research use only. Not for human or veterinary use, consumption, or therapeutic application. No medical claims are made.
